NCT07344376 An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta) Status COMPLETED Phase PHASE3
NCT06031259 Extension Study of Idursulfase-IT Along With Elaprase in Children and Adults With Hunter Syndrome and Cognitive Impairment Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05795361 Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome Status AVAILABLE Phase N/A
NCT05494593 A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II) Status WITHDRAWN Phase PHASE4
NCT05422482 A Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients with MPS Ⅱ Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05058391 A Study of Elaprase in Children and Adults With Hunter Syndrome (Mucopolysaccharidosis II) in India Status COMPLETED Phase PHASE4
NCT03582449 Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701) Status COMPLETED Phase N/A
NCT02455622 Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age Status COMPLETED Phase PHASE4
NCT02412787 Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094 Status COMPLETED Phase PHASE2/PHASE3
NCT02171104 MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02055118 Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment Status COMPLETED Phase PHASE2/PHASE3
NCT02044692 The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients Status UNKNOWN Phase N/A
NCT01822184 Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II) Status COMPLETED Phase N/A
NCT01506141 An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairment Status COMPLETED Phase PHASE1/PHASE2
NCT01449240 Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome Status COMPLETED Phase N/A